Enteric Diseases in Spain 2014: Market Outlook and Emerging Opportunities

◆発行会社(調査会社):Venture Planning Group
Local LicenseUSD2,200 ⇒換算¥244,200見積依頼/購入/質問フォーム
Global LicenseUSD4,800 ⇒換算¥532,800見積依頼/購入/質問フォーム
DataPackUSD1,450 ⇒換算¥160,950見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規販売代理店です。Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

[u]About This Report[/u]

This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.


The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.
Contains 322  pages and 17 tables




★調査レポート[Enteric Diseases in Spain 2014: Market Outlook and Emerging Opportunities]販売に関する免責事項
★調査レポート[Enteric Diseases in Spain 2014: Market Outlook and Emerging Opportunities]についてメールでお問い合わせ